335 related articles for article (PubMed ID: 30443341)
1. Clinical management of herpes simplex virus infections: past, present, and future.
Whitley R; Baines J
F1000Res; 2018; 7():. PubMed ID: 30443341
[TBL] [Abstract][Full Text] [Related]
2. A new promising candidate to overcome drug resistant herpes simplex virus infections.
Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
[TBL] [Abstract][Full Text] [Related]
3. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
4. Herpes Simplex Virus and Interferon Signaling Induce Novel Autophagic Clusters in Sensory Neurons.
Katzenell S; Leib DA
J Virol; 2016 May; 90(9):4706-4719. PubMed ID: 26912623
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
[TBL] [Abstract][Full Text] [Related]
6. [Herpes simplex virus vaccine studies: from past to present].
Us D
Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
[TBL] [Abstract][Full Text] [Related]
7. Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure.
Parker ZM; Pasieka TJ; Parker GA; Leib DA
J Virol; 2016 Dec; 90(23):10789-10799. PubMed ID: 27681121
[TBL] [Abstract][Full Text] [Related]
8. [Status quo of the researches on HSV vaccines].
Gao J; Lu JC; Huang YF
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):60-4. PubMed ID: 19288753
[TBL] [Abstract][Full Text] [Related]
9. Vaccines for herpes simplex virus infections.
Koelle DM
Curr Opin Investig Drugs; 2006 Feb; 7(2):136-41. PubMed ID: 16499283
[TBL] [Abstract][Full Text] [Related]
10. Development of Genome Editing Approaches against Herpes Simplex Virus Infections.
Zhang I; Hsiao Z; Liu F
Viruses; 2021 Feb; 13(2):. PubMed ID: 33671590
[TBL] [Abstract][Full Text] [Related]
11. Status of vaccine research and development of vaccines for herpes simplex virus.
Johnston C; Gottlieb SL; Wald A
Vaccine; 2016 Jun; 34(26):2948-2952. PubMed ID: 26973067
[TBL] [Abstract][Full Text] [Related]
12. Herpes Simplex Virus 1 Mutant with Point Mutations in
Mostafa HH; Thompson TW; Konen AJ; Haenchen SD; Hilliard JG; Macdonald SJ; Morrison LA; Davido DJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321311
[TBL] [Abstract][Full Text] [Related]
13. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
14. [Battle with herpes for 37 years].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
[TBL] [Abstract][Full Text] [Related]
15. Agents and strategies in development for improved management of herpes simplex virus infection and disease.
Kleymann G
Expert Opin Investig Drugs; 2005 Feb; 14(2):135-61. PubMed ID: 15757392
[TBL] [Abstract][Full Text] [Related]
16. Chromatin control of herpes simplex virus lytic and latent infection.
Knipe DM; Cliffe A
Nat Rev Microbiol; 2008 Mar; 6(3):211-21. PubMed ID: 18264117
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus type-1: replication, latency, reactivation and its antiviral targets.
Pires de Mello CP; Bloom DC; Paixão IC
Antivir Ther; 2016; 21(4):277-86. PubMed ID: 26726828
[TBL] [Abstract][Full Text] [Related]
18. The many challenges of facial herpes simplex virus infection.
Esmann J
J Antimicrob Chemother; 2001 Feb; 47 Suppl T1():17-27. PubMed ID: 11160032
[TBL] [Abstract][Full Text] [Related]
19. HSV antivirals - current and future treatment options.
Birkmann A; Zimmermann H
Curr Opin Virol; 2016 Jun; 18():9-13. PubMed ID: 26897058
[TBL] [Abstract][Full Text] [Related]
20. Bioactive natural products with anti-herpes simplex virus properties.
Hassan ST; Masarčíková R; Berchová K
J Pharm Pharmacol; 2015 Oct; 67(10):1325-36. PubMed ID: 26060043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
